CLN — Celon Pharma SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Celon Pharma SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	Interim Report	ARS	ARS
Standards:	PAS	PAS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	148	66.7	44	228	165
Net Total Accounts Receivable
Net Total Receivables	39.8	45.5	41	27.2	33.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	214	144	119	279	238
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	191	243	331	329	342
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	564	591	532	707	643
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19.7	26	114	86.4	116
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	115	146	187	153	163
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	449	445	345	554	480
Total Liabilities & Shareholders' Equity	564	591	532	707	643
Total Common Shares Outstanding